Cholestasic toxic hepatitis due to clopidogrel in a patient with multiple conditions

Authors

  • D. Etxeberria-Lekuona Hospital García Orcoyen
  • I. Méndez-López
  • M.R. Mercado
  • J. Oteiza
  • M. Arteaga
  • V. Jarne

DOI:

https://doi.org/10.23938/S1137-6627/2016000100017

Keywords:

clopidogrel, toxicidad, hepatotoxicidad, biopsia

Abstract

Clopidogrel is a thienopyridine-class antiplatelet drug that is commonly used in ischemic heart disease, cerebrovascular disease and peripheral artery disease. Liver toxicity due to this drug is very infrequent. We found a mere 16 cases in the literature, and in only two of them was a liver biopsy carried out. We report the case of a 78 year old patient with multiple conditions affected by severe toxic cholestatic hepatitis due to clopidogrel and the results of the liver biopsy performed. Hepatitis was resolved after discontinuing the drug.

Based on the characteristics of this case and other previously published cases, we review the characteristics of toxic hepatitis due to clopidogrel and its diagnosis and treatment.

Key words. Clopidogrel. Toxicity. Hepatotoxicity. Biopsy.

Downloads

Download data is not yet available.

Downloads

Published

2016-04-29

How to Cite

Etxeberria-Lekuona, D., Méndez-López, I., Mercado, M., Oteiza, J., Arteaga, M., & Jarne, V. (2016). Cholestasic toxic hepatitis due to clopidogrel in a patient with multiple conditions. Anales Del Sistema Sanitario De Navarra, 39(1), 143–148. https://doi.org/10.23938/S1137-6627/2016000100017

Issue

Vol. 39 No. 1 (2016)

Section

Clinical notes

License

Copyright (c) 2016 Anales del Sistema Sanitario de Navarra

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.